CAV1 and metabolic dysfunction-associated steatotic liver disease: Moreover, truncated OxPAPC down-regulated the expression of Cav1 (caveolin 1), which has been shown to increase hepatic lipid droplet size in NAFLD (55–57), and up-regulated Slc25a1, which has recently been associated with hepatic steatosis and glucose intolerance by dysregulation of hepatocyte metabolism (58).